1989
DOI: 10.1016/0166-6851(89)90002-9
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria as the site of action of tetracycline on Plasmodium falciparum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
39
1

Year Published

1991
1991
2017
2017

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(41 citation statements)
references
References 10 publications
1
39
1
Order By: Relevance
“…The mechanism of the antibacterial action of clindamycin is well established (reviewed by Steigbigel [15] (7). The inhibition of mitochondrial protein synthesis could result in markedly delayed antiparasitic activity if the intracellular parasites were not absolutely dependent on oxidative phosphorylation for energy but could also use glycolysis.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of the antibacterial action of clindamycin is well established (reviewed by Steigbigel [15] (7). The inhibition of mitochondrial protein synthesis could result in markedly delayed antiparasitic activity if the intracellular parasites were not absolutely dependent on oxidative phosphorylation for energy but could also use glycolysis.…”
Section: Discussionmentioning
confidence: 99%
“…If tetracycline had attained high intraparasitic concentrations, 80S ribosomal inhibition could play a role in the antimalarial effect. Tetracycline acts on mitochondria (22) and depresses the activity of dihydroorotate dehydrogenase, an iron-dependent enzyme of the pyrimidine pathway in P. falciparum (23,41), presumably due to the inhibition of enzyme protein synthesis. Doxycycline reduces the levels of malaria nucleoside 5Ј-triphosphates and deoxynucleoside 5Ј-triphosphates (58) and has shown inhibitory effects against preerythrocytic stages (28).…”
Section: Discussionmentioning
confidence: 99%
“…The ribonucleic constituents are also considered as novel candidates for drug target of antimalarial drugs. Therefore, the new ribosomal proteins identified in this study can be potential candidates for malaria (Bottger, 2007;Clough et al, 1997;Rogers et al, 1997;Camps et al, 2002;Kiatfuengfoo et al, 1989;Yassin and Mankin, 2007;Sidhu et al, 2007). The transporter proteins in Plasmodium are yet to be exploited as drug targets and needs to be more investigated by the scientific community (Jana and Paliwal, 2007).…”
Section: (A) Cellular Componentmentioning
confidence: 99%